Related Experiment Video
Updated: Jul 1, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
The Benefits and Harms of Lung Cancer Screening in Individuals With Comorbidities
Minal S Kale1, Keith Sigel1,2, Arushi Arora1,3
1Department of Medicine, Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Chronic diseases, such as COPD and diabetes, reduce the life-years gained from lung cancer screening. This finding is crucial for clinicians discussing screening benefits and harms with patients who have comorbidities.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Individuals at high risk for lung cancer often have smoking-related comorbidities.
- Comorbidities can affect the benefit-to-harm ratio of lung cancer screening.
- Chronic diseases are underrepresented in lung cancer screening trials.
Purpose of the Study:
- To determine the impact of chronic diseases on lung cancer screening benefits and harms.
- To quantify life-years gained from lung cancer screening in individuals with specific comorbidities.
Main Methods:
- A validated lung cancer screening microsimulation model was extended.
- The model incorporated the impact of chronic diseases on complications, quality of life, and mortality.
- Outcomes were life-years gained per 100,000 individuals aged 50-80 with chronic obstructive pulmonary disease, diabetes mellitus, heart disease, or history of stroke.
Main Results:
- Comorbidities reduced life-years gained from lung cancer screening compared to individuals without comorbidities.
- For ages 50-54, life-years gained varied: 4296 (no comorbidities), 3462 (COPD), 3260 (heart disease), 3031 (diabetes mellitus), and 3257 (stroke).
- Greater reductions in life-years gained were observed in individuals with multiple comorbidities, with similar patterns across all age groups studied.
Conclusions:
- Comorbidities significantly decrease the life-years gained from lung cancer screening.
- These findings can assist clinicians in counseling patients with comorbidities about lung cancer screening.
- The study highlights the need to consider individual patient health status when evaluating screening efficacy.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Preventive Healthcare Services
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Statistical Methods for Analyzing Epidemiological Data

